Recent results by Richardson et al. (Mech. Dev., 52 (1995) [165][166][167][168][169][170][171][172][173][174][175][176][177] suggest that the Xenopus Rel gene XrefA may be involved in the formation of the head and tail of the early embryo. We present evidence to suggest that wild-type XrelA also has a role in dorsoventral development. XreL4 overexpression in the dorsal side of embryos reduces dorsal development and attenuates in vitro dorsal morphogenetic movements. XreL4 also strongly reduces axis duplication caused by overexpression of a dominant negative mutant of Xenoplcs glycogen synthase kinase-3/?. Our results indicate that XrelA may have a role in dorsoventral patterning in early embryos.
Introduction
The Rel family of proteins represents a large group of trans-acting transcription factors that have been implicated in development, differentiation and oncogenesis. The Rel family members include the protooncogene c-rel, the mammalian lymphocyte transcription factor NF-KB and Dorsal, the embryonic dorsoventral patterning morphogen of the fruitfly, Drosophila melunogasfer. The Rel transcription complex is composed of two subunits that bind to a consensus sequence on target genes. Unlike many other transcription factors, Rel protein activity is regulated at the level of subcellular localization. For instance, the NF-KB transcription complex is composed of a 50 kDa (~50 or NF-KB~) and 65 kDa (~65 or RelA) subunit that is retained in the cytoplasm of quiescent Blymphocytes by a third inhibitory subunit, called brB. Upon activation, NF-KB is released by kB and allowed to enter the nucleus. This mode of activation, therefore, represents a convenient means to rapidly mobilize new genes for dynamic cellular events essential for development and differentiation (for reviews, see Thanos and Maniatis, 1995; Verma et al., 1995 Although the importance of the Dorsal morphogen in body patterning of Drosophila cannot be understated (for review, see Wasserman, 1993) , a significant contribution to our understanding of the activity of Rel proteins will be the discovery of their roles in early vertebrate embryogenesis. In mice, removal of the gene encoding the ~50 subunit by targeted disruption resulted in immune defective neonates that had developed to term with normal embryogenesis (Sha et al, 1995; Weih et al, 1995) . Knockout of the RelA (~65) gene resulted in embryo death at 15-16 days of gestation associated with liver degeneration (Beg et al, 1995) but it is not clear whether these RelAdeficient embryos have any other body axis defects.
The mRNA of at least one vertebrate member of the rel family, XrelA, is expressed in Xenopus laevis oocytes and early embryos. The mRNA is relatively evenly expressed over the whole embryo during the early embryonic stages (Kao and Hopwood, 1991; Richardson et al, 1994) , but the protein becomes localized to the nuclei of animal and equatorial cells at the midblastula stage (Bearer, 1994) .
In a carefully controlled study, Richardson et al. (1995) proposed that the XrelA gene has a role in formation of the termini of the early embryo but, unlike the Dorsal protein in Drosophila, it is not involved in dorsoventral patterning. They overexpressed XrelA in embryos and assessed the effects it had on development.
High doses of XrelA caused gastrulation arrest while lower doses resulted in embryos having tissue disruptions, particularly in the mid-trunk regions. Interestingly, expression of early markers of dorsoanterior-specific and mesoderm-specific genes was not significantly affected by XrelA even though there were dramatic effects on the axes of the injected embryos.
We were intrigued by this apparent paradox and reasoned that there may be other factors involved in XrelA effects. By taking a slightly different experimental embryological approach, we have extended the findings of Richardson and co-workers (1995) . In this paper, we show that embryos injected with XrelA RNA only in the dorsal region develop defects similar to those injected by Richardson et al.. However, a proportion of our embryos completely fail to develop dorsal structures. It is possible that XrelA manifests this ventralizing effect early, since morphogenetic movements characteristic of dorsal mesoderm can be attenuated by XrelA. Finally, we show that XrelA RNA can reverse the strong dorsal axis-promoting effects of a dominant mutant of Xenopus glycogen synthase kinase-3/3 (Xgsk-3B). These results are compelling enough for us to conclude that XrelA has a significant effect on dorsoventral patterning.
Results

I.
Overexpression of XrelA into the dorsal marginal zone causes a variety of dorsoanterior-reduced embryonic phenotypes.
We initially injected XrelA RNA into two-cell embryos in order to repeat the results obtained by Richardson et al. (1995) . They did not report the location of their injection site but we assumed it was at the animal pole. Effects from injection of wild type XrelA RNA at the animal pole appear at late gastrula (Stage 12). The epidermal cells surrounding the injection site form darkly pigmented protrusions described by as 'warty' protuberances . Apart from this benign effect, there is no visible effect on the development of the body axis, since these embryos form normal tadpoles.
Since animal pole injections appeared to have no effect, we injected into equatorial regions (marginal zone) of the embryo as cells derived from this region of the egg determine the body plan. RNA was injected at the animalvegetal pigment border at the two-cell stage on either side of the cleavage furrow (dorsal or ventral). We wanted to test whether overexpression of XrelA had preferential effects if injected into either the dorsal or ventral marginal zone. To fix the position of the dorsal side, fertilized eggs were immersed in agarose wells in 4% Ficoll solution and tilted with the sperm entry point facing gravity as described previously (Gimlich, 1986) . When injected into the ventral side, 1 or 2 ng of XrelA RNA had little or no effect on development in 80-85% of the embryos injected (Fig. 1A) . The remaining 15-20% had mild effects such as a kinked tail. Injections of our deletion mutant in the ventral side at 1 or 2 ng had no effect on development.
Injections into the dorsal side, however, caused severe phenotypes similar to those described by Richardson et al. (1995) . XrelA injected dorsally at 3 ng or higher (data not shown) caused embryos to arrest at gastrulation, as described previously . Of the embryos injected with 2 ng of XrelA dorsally, 65% failed to develop any dorsal axial structures (Figs. 1A and 2) and they resemble completely ventralized UV-irradiated (Grant and Wacaster, 1972) embryos (Fig. 1A) . These embryos undergo epiboly incorporating all of the yolk and complete blastopore closure, but it is not clear whether internal morphogenetic movements are normal. Injection of the deletion mutant into the dorsal side did not have an effect on development (Fig. 2) . A percentage of embryos develop a split-tail phenotype. We have no evidence presently to suggest that this phenotype does not result from a non-specific effect so we do not include these data in our analyses.
The rest of the embryos injected dorsally developed axial abnormalities similar, at least superficially, to those found by Richardson et al. (1995) . These include embryos that have kinked backs (kinked) and/or small heads (microheads) and shortened tails (Fig. 1B) to those that completely lack all dorsal structures (anaxial) (Fig. 1A) . The trend in the frequencies of phenotypes observed seems to correlate with dosage. That is, higher doses resulted in the generation of more anaxial embryos while the lower doses caused embryos to have the kinked or microhead phenotypes (Fig. 2) .
These results show that we can reproduce the effects that Richardson et al. (1995) achieved by XrelA injection but only if we inject XrelA specifically on the dorsal side. The mild effects associated with high dosage ventral injection are probably due to 'spill-over' or diffusion of XrelA RNA to the dorsal side. We next wanted to see if our phenotypes matched those of Richardson et al. (1995) when we examined them internally.
Dorsal injection of XrelA causes embryos to lose dorsal axial structures in a dose-dependent manner
We reasoned that XrelA might be exerting its effects on dorsal mesoderm because embryos were sensitive only if they were injected in the dorsal equatorial regions. Indeed, the external morphologies of the embryos suggested alterations in dorsal and anterior development.
The embryos with a kinked trunk, when serially sectioned, appeared to have all the normal complement of structures, except for disruptions in somite tissue, as described by Richardson et al. Our microhead embryos also had fairly normal looking structures but there was a single eye or the eye was absent, there was an approximately 30% deficiency in notochord tissue (data not shown) and the tail was shortened. The anaxial embryos, when serially sectioned, did not contain any notochord tissue at all, when examined at stage 28-30. The complete loss of notochord tissue in our embryos is at variance with the results obtained by Richardson et al. (1995) who reported that although these embryos superficially resemble UVirradiated embryos, they still differentiate notochord and disrupted neural and somite tissue. In this respect, our experiments generated embryos more closely resembling embryos ventralized by UV-light. Somite tissue was also disrupted in our XrelA-injected embryos as described by Richardson et al. (1995) , but whole mount in situ hybridization analysis using cardiac actin (Mohun et al, 1984) as a probe (Fig. 3A) revealed that the total amount of somite tissue was also reduced in embryos injected in the dorsal side with XrelA to virtually nil in the anaxial embryo (Fig. 3B ). In contrast, there was strong expression of /T-globin (Fig. 3C ), a marker of ventral blood formation (Weber et al, 1991) in anaxial embryos (Fig. 3D ). This domain of expression of /I-globin in anaxial embryos is shared with that of embryos completely ventralized by ultraviolet irradiation (see, for example, Kao and Bernstein, 1995) . These observations indicate that the phenotypes generated by dorsal overexpression of XrelA lack dorsal structures but continue to accumulate ventral tissues.
XrelA attenuates convergent extension
The morphogenetic movements of gastrulation in Xenopus embryos have been studied extensively and a number of principles are well established (for review, see Keller, 1991) . Briefly, the movements consist of several processes by which the ectodermal cells through the process of epiboly engulf the yolky endodermal cells. This is accompanied by the involution of mesodermal cells which reside in an annulus of tissue in the deep equatorial zone of the embryo. In the dorsal side of the embryo, the involuting mesodermal cells undergo convergent extension, or a narrowing and lengthening, which results in the movement of cells anteriorly and dorsally, culminating in elongation of the body plan.
The origin of phenotypes we have observed by XrelA overexpression might be explained by alterations in such gastrulation movements. A number of agents are known to alter gastrulation, such as UV irradiation and polysulfonated substances like suramin and heparin Mitani, 1989) , lithium ions and deuterium oxide (Kao and Elinson, 1988; Scharf et al, 1989) , as well as overexpression of the ventral-specific gene, Xvent-1 (Gawantka et al., 1995) . In all of these cases, the embryos develop pattern abnormalities as would be predicted by the corresponding gastrulation anomalies. Our embryos injected dorsally with XrelA RNA developed a lack of dorsal structures, so one prediction would be that, like the ventralizing agents such as UV light or Xvent-1 (Gawantka et al., 1993, the dorsal movements of gastrulation would be reduced. Richardson et al. (1995) stated briefly. that gastrulation appeared superficially to be normal in XrelA-injected embryos, but they did not measure any of the parameters which define gastrulation movements. We initially measured the rate of closure of the blastopore in embryos injected dorsally with XrelA to determine if dorsal lip formation was occurring on schedule. Rate of blastopore closure has been used as a means to measure convergence of the marginal zone in embryos (Keller, 1981) and we used this parameter to determine if XrelA affected this process. To our surprise, embryos injected dorsally with XrelA RNA did not form a dorsal lip, and a circular blastopore lip formed at a delayed time (Fig. 4) , when compared to normal embryos. This was unexpected since Richardson et al. (1995) did not see defects in the dorsal lip of their embryos. Delay of blastopore closure was dose-dependent with embryos injected with higher doses
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Nleuwkoop and Faber Stage Fig. 4 . XrelA RNA dorsal injection delays blastopore closure. Blastopore and embryo diameters were measured during gastrulation (horizontal axis) using a calibrated eyepiece micrometer in a dissecting microscope. Diameters were normalized by dividing by embryo diameter (vertical axis). Embryos were measured from two different batches of eggs for each of the following treatments: 0.9 ng XrelA RNA injected dorsally, n = 13; 0.5 ng XmlA RNA injected dorsally, n = 15; 0.9 ng XrelA RNA injected ventrally, R = 13; 0.9 ng A304 injected dorsally, n = 10; and control embryos, n = 10. Error bars are standard deviations.
causing greater delay. Injection of control RNA did not significantly affect blastopore closure.
It is possible to mimic the elongation movements associated with dorsal development in vitro by treating animal cells at the early blastula stage with factors known to cause differentiation of dorsal tissues (for review, see Kessler and Melton, 1994) . We have taken advantage of this technique to examine what effect XrelA RNA injection has on convergent extension, a central process to dorsal differentiation.
We treated animal caps with media conditioned from XTC cells, which contains activin, a strong dorsoanteriorizing growth factor, and is able to induce convergent extension in vitro (Symes and Smith, 1987; Smith et al, 1990; Thomsen et al, 1990) . As expected, animal caps isolated from uninjected and control-injected embryos that are exposed to XTC-conditioned medium (XTC-CM) undergo dramatic elongation when control embryos are gastrulating (Fig. 5A ). Animal caps from embryos injected with 10-1000 pg of XrelA and treated with XTC-CM, however, undergo reduction of elongation relative to the injection dosage (Fig. 5A ). Low dosages such as 100 pg XrelA RNA caused a reduction of about 50-75% in the average length of XTC-CM-treated explants (Fig.  5B) , while at the other end of the range, 500-1000 pg of XrelA mRNA caused complete reduction of elongation, and the animal caps appeared indistinguishable from the untreated cases. These findings indicate that XrelA reduces activin-induced elongation of animal caps.
When the explants shown in Fig. 5 were assayed during gastrulation for the dorsal and anterior-specific molecular markers cardiac actin, Xlhboxl, and the nonmuscle mesoderm-specific marker Xtwi, there is a downregulation of these genes (Fig. 5C ). The expression levels of the posterior gene Xhox3 seemed somewhat variable between treatments, but certainly it was always present in XrelA-injected animal caps. It is clear, also, that the expression of Xwnt-8, a gene expressed specifically in the ventral mesoderm of gastrulae, is maintained in XrelAinjected animal caps.
The injection doses we used are far below those required to cause axis defects in whole embryos, as shown above and by Richardson et al. (1995) . This argues that the attenuation of elongation we observed is not likely due to non-specific effects but rather reflects a true cellular effect that may account for the observed phenotypes in whole embryo injection. It is possible that, as mentioned by Richardson et al. (1995) some general, non-specific transcriptional inactivation (squelching) is taking place in our samples since the general RNA marker ef-la is slightly reduced. However, when XrelA is injected into embryos at levels much higher than we have injected here, it does not inhibit the transcription of all genes and the levels of poly (A)+ RNA do not change appreciably after XrelA injection (Richardson et al., 1994) , arguing against a general inhibition of transcription.
In addition, we did not see changes in the levels of Xwnt8 expression, indicating that at least not all transcription is repressed.
XrelA has strong ventroposteriorizing activity
To confirm that XrelA is associated with dorsoventral patterning, we tested its effects on embryos overexpressing a catalytically inactive dominant-negative mutant protein of Xenopus glycogen synthase kinase-3 (Xgsk-3/I), called R85, which has very strong dorsalizing activity when injected into the ventral side (Dominguez et al, 1995) (Fig. 6B) . As expected, the dominant negative Xgsk-3/I mutant, R85, at 10 ng had no effect when injected on the dorsal side (Fig. 6A) , but induced full secondary axes in the ventral side (Fig. 6B) . These secondary axes ran the complete length of the embryo and had a full complement of dorsal structures including heads, notochords, neural tubes and somites. They formed bona fide conjoined twins caused by the dorsalizing action of R85.
When we coinjected XrelA, however, secondary axis formation by R85 overexpression was reduced in a dosedependent manner (Figs. 6D and 7, Table 1) while coinjection of A304 control RNA had no effect on R85 overexpression (Fig. 6C, Table 1 ). More importantly, the reduced secondary axes were shorter in length and showed gradual reduction of dorsoanterior structures dependent on dosage of XrelA (Fig. 7) . All of the embryos injected K.R. Kao, A. Lockwood /Mechanisms qf Development 58 (1996) at all doses gastrulated normally as they showed no visible defects in yolk plug closure. Six embryos from each dosage group were serially sectioned and examined in cross-section to determine the extent of development of the secondary axes. In all six embryos injected in the ventral side with 10 ng of R85 RNA only, the secondary axes had complete or nearly complete head structures and the trunks all had a full complement of dorsal structures including notochords, somites and neural tubes (Fig. 7A) .
In four out of six embryos injected with 10 ng of R85 RNA and 0.5 ng of XrelA RNA, the secondary axes lacked heads and notochords but had fused somites and abnormally shaped neural tubes (Fig. 7B) . The other two also lacked heads, notochords and somites and also had a small, abnormally shaped neural tube (Fig. 7C) . None of the six embryos injected with 10 ng R85 RNA and 1 ng of XrelA RNA had a secondary axis. These embryos had small ventral epidermal protrusions (Fig. 7D ) reminiscent of that seen when XrelA alone is injected into the ventral side of embryos. These results indicate that XrelA has dose-dependent Fig. 7 . Each PCR reaction was performed on cDNA derived from RNA equal to 6/100ths of total RNA from a single animal cap. Although there was variability between different experiments as to the absolute levels of expression, similar trends were obtained from at least three independent experiments XlhBoxl is an anterior trunk marker (Cho et al., 1988) while cardiac actin is a marker for muscle (Mohun et al., 1984) . Xtwi is expressed in notochord, lateral mesoderm and neural crest (Hopwood et al., 1989) . Both Xwnt8 (Christian et al., 1991) ventroposteriorizing activity. The lack of notochords and fusion of somites in the midline in embryos coinjected with a moderate XrelA RNA dose is a hallmark of embryos ventralized by UV irradiation (Youn and Malacinski, 1981) and is observed in embryos microinjected in the dorsal side with RNA from the ventrally expressed homeobox gene, Xvent-1 (Gawantka et al., 1995) . Furthermore, the ability of XrelA to rescue the effects of the dominant negative Xgsk-38 mutant is accompanied by normal, unhindered morphogenetic movements of gastrulation.
Discussion
Our results confirm and significantly extend the results obtained previously by Richardson et al. (1995) , who also reported the effect of XrelA overexpression.
From morphological studies of the effects of wild-type XrelA overexpression, they concluded that XrelA has a role in ante- Table 1 XrelA rescues dorsalizing activity of a dominant-negative mutant of Xgsk-3p
rior-posterior patterning but not dorsoventral patterning.
We have arrived at a somewhat different conclusion. Our evidence indicates that XrelA overexpression does indeed affect dorsoventral patterning by negatively regulating dorsal development.
XrelA has preferential effects on the dorsal marginal zone of the embryo. Injections of XrelA RNA into the dorsal marginal zone at dosages sufficient to completely reduce dorsal axis formation were ineffective or mildly effective when injected into the ventral .marginal zone. This indicates that the target of XrelA injection resides in the dorsal region of the embryo. Furthermore, injections into the ventral regions did not affect normal development, indicating that the overexpression of XrelA does not result in a non-specific toxic effect. The generation of axis-reduced phenotypes might be the result of alterations in gastrulation movements since injection of XrelA into activin-treated animal caps causes an attenuation of convergent extension movements. Finally, we have shown that XrelA counteracts the effects of a dominant negative Xgsk-3/I mutant, a molecule that has strong dorsal axis-forming capabilities. In this 'complementation' effect, we did not find a truncation or disruption of mid-trunk structures in the secondary axes solely, as might be predicted . Instead we found a dose-dependent loss of all dorsal and anterior structures including heads in the secondary axis, reflecting the observations we made on embryos injected with XrelA alone into the dorsal side. These embryos undergo yolk plug closure and no non-specific gastrulation defects occurred. These results argue strongly in favor of a ventroposteriorizing effect of XrelA. We therefore propose that XrelA has a potential role in dorsoventral patterning.
trations of XrelA, except for pintallavis, which is normally expressed in the dorsal lip, at the vegetal side of the marginal zone (Ruiz i Altaba and Jessell, 1992) . Except for the highest dosages of XrelA (which caused gastrula arrest), uncertainty in the injection site could also account for an apparent lack of correlation between dosage and severity of phenotypes observed by them. Furthermore, presence of the dorsal lip bottle cells is not correlated with normal gastrulation movements (Keller, 1981) , so it is difficult to assume normal gastrulation solely on this criterion.
The major difference between our experiments and those of Richardson et al. (1995) is that we injected specifically in the dorsal marginal zone of the two-cell embryo. This may be an important aspect of experimental design, especially when considering the ability of the overexpressed protein and/or RNA to diffuse to target regions of the embryo that are sensitive to XrelA at a particular concentration.
There is ample evidence indicating that, in many cases of RNA injection, the effects of the overexpressed gene are largely manifested when injected only in certain regions. Some notable examples of this phenomenon are Xgsk-/? (Dominguez et al., 1995; He et al., 1995; Pierce and Kimelman, 1995) , XBMP-4 (Dale et al., 1992; Jones et al, 1992; Fainsod et al., 1994) , ADMP (Moos Jr. et al., 1995) and Xvent-1 (Gawantka et al., 1995) all of which, like XrelA, ventralize embryos when injected into the dorsal side.
Our results support the view that some agents, such as UV light and polysulfonated substances (Kao and Elinson, 1988; Gerhart et al, 1989; Mitani, 1989) , and more recently the Xvent-1 gene (Gawantka et al., 1995) , are able to alter normal dorsoanterior patterning by altering gastrulation movements, specifically delaying blastopore lip formation, attenuating convergent extension, and reducing notochord formation, similar to our observations on dorsally injected XrelA. On the other hand, there are genes like Xhox3 (Ruiz i Altaba and Melton, 1989) XBMP-4 (Dale et al., 1992; Jones et al., 1992; Fainsod et al., 1994) and ADMP-3 (Moos Jr. et al., 1995) which cause ventralization without apparently altering gastrulation. However, gastrulation events like convergent extension and blastopore closure were not examined in detail in these ventralized embryos. Perhaps the latter agents act 'downstream' of gastrulation, while the former agents, including, we propose, XrelA, are involved in influencing gastrulation itself and the subsequent patterning of the embryo associated with these influences. Richardson et al. (1995) did not report the location of their injections into the embryo. This significant difference in experimental approach may be sufficient to explain the differences in results that we obtain compared to theirs. Richardson et al. (1995) describe effects of XrelA overexpression as being only in the mid trunk. According to fate maps of the pregastrula embryo, mid trunk mesoderm (somites) develops from the animal border of the dorsolateral marginal zone (Keller, 1976; Dale and Slack, 1987) . We suggest that the effective concentrations of XrelA in animally injected embryos may only reach the animal-most regions of the marginal zone, thus affecting primarily the future trunk region, causing it, as described by Richardson et al., to be disrupted. On the other hand, in our experiments, we injected into the future dorsal side affecting potentially all of the dorsal structures.
Rel-related proteins are able to both activate and repress the transcription of target genes. For instance, the Dorsal morphogen specifies the differentiation of mesoderm in the ventral region of the Drosophila embryo by activating some genes like twist (Pan et al., 1991; Thisse et al., 1991; Jiang et al., 1992) but also represses specific genes like zerkniillt (Jiang et al., 1992) and tolloid (Kirov et al., 1994) (Hopwood et al., 1989) although it is not known whether Xtwi is required for dorsoanterior development. One possibility is that XrelA overexpression acts in a dominant negative fashion, repressing endogenous XrelA or other Rel proteins that may be necessary for normal dorsoanterior development. The differences in injection site also might explain The Xenopus glygogen synthase kinase-3fl (Xgsk-3fl) why Richardson et al. (1995) did not see any effect on gene, the Xenopus homologue to Drosophila zeste-white dorsal lip formation and expression of various mesoder-3/shaggy (Dominiguez et al, 1995; He et al, 1995; Pierce ma1 and dorsoanterior markers. It is possible that the and Kimelman, 1995), is a serine/threonine kinase that is markers they tested are normally expressed at a distance regulated by the wingless gene (Siegfried et al, 1992) . from an effective XrelA concentration.
Indeed, expression There is no evidence of ventroposterior RNA localization of these markers was depressed only in very high concenof Xgsk-3fl, but its overexpression in dorsal regions, like that of XrelA, is able to reduce dorsoanterior development in a dominant manner while overexpression of dominant negative Xgsk-38 mutants in ventral regions induces a complete secondary axis (Dominiguez et al, 1995; He et al, 1995; Pierce and Kimelman, 1995) . There are other ventralizing genes such as Xvent-1, XBMP4 and ADMP which are able to induce ventral development to various degrees and whose dominant negative counterparts may or may not cause an opposite phenotype. Our results show that XrelA overexpression in the dorsal marginal zone mimics the effects of these agents and it will be interesting to determine the various interactions of these genes in ventral development.
Animal cap dissections
Embryos were raised to stage 8 and animal caps dissected in NAMl2. The area of dissection was limited to a small circle about 30" from the animal pole avoiding any marginal zone cells, or large, vegetal cells. Explants were either cultured in NAM/2 or in full-strength XTCconditioned medium (kindly provided by Dr. L. Gillespie) for 2-3 h, after which explants were rinsed and cultured in NAMl2.
Reverse transcription-polymerase chain reaction (RT-PCR)
4. Materials and methods
Plasmid construction
The coding region of the XrelA cDNA r117 was amplified using polymerase chain reaction (PCR) with oligonucleotide primers (GSD, Toronto) which placed NcoI and BstEII sites at the ends for subcloning into the BstEIU NcoI pSP64T vector (Krieg and Melton, 1984) . The resulting plasmid was named pXrelA-SP64T.
For an RNA control, an antisense fragment was amplified using the above primers with the reverse orientation and subcloned into pSP64T to make pas-SP64T.
A plasmid containing a mutation deleting the carboxyl terminal sequences outside the Rel Homology Domain (RHD) was made similarly with a 3' primer complementary to the end of the RHD at amino acid residue 304 (Kao and Hopwood, 1991) and named pA304-SP64T (Fig. 1) .
Total RNA was extracted from up to two embryos or pools of 10-20 animal cap explants using NETS (100 mM NaCl, 10 mM EDTA, 10 mM Tris-HCl (pH 8) 0.2% sodium dodecyl sulfate) and phenol/chloroform and precipitated in ethanol. Samples were treated with 1 U of RNAse-free DNase (RQl, Promega) and 20-40 U of RNAguard RNAase inhibitor (Pharmacia). RT-PCR was performed on approximately 6/1OOths of an animal cap essentially as described by Hemmati-Brivanlou and Melton (1994) for cardiac actin and ef-la. The Tm for each of the primer pairs for ef-la, XlhBoxl, Xhox3, Xwnt8 and cardiac actin was 55°C and for Xtwi 60°C and the number of cycles for each primer set was 24, except for ef-la for which 21 cycles was used. The nucleotide positions for each primer set were as follows: XlhBoxl, upper 1501 XlhBoxl, upper -1520 XlhBoxl, upper , lower 1754 XlhBoxl, upper -1735 Xhox3, upper 1949 Xhox3, upper -1967 Xhox3, upper , lower 2210 Xhox3, upper -2229 Xtwi, upper 166183, lower 333-316; and Xwnt8, upper 880-899, lower 1132-l 113 . Capped (New England Biolabs), synthetic mRNA was made as described (Krieg and Melton, 1984 ) from pXrelA-SP64T, pA304-SP64T and pas-SP64T linearized with EcoRI and from R85-SP64T, a plasmid constructed similarly but encoding a dominant negative mutant of Xgsk-3,8 which has a single base substitution resulting in the replacement of a lysine residue with arginine at position 85 (Dominguez et al, 1995) .
Analysis of embryos
Whole mount in situ hybridization was carried out using probes synthesized from the 3' untranslated region of Xenopus cardiac actin (a gift from T. Mohun) and Xenopus /?-globin ( a gift from L. Zon) according to Harland (1991) .
Embryos Acknowledgments
Embryos were obtained as described (Kao and Elinson, 1988) and staged according to Nieuwkoop and Faber (1994) . Injection needles were made with a Narashige electrode puller and a bevelling grinder. XrelA mRNA was microinjected into two-cell embryos in 4% Ficoll dissolved in half strength normal amphibian medium (NAM/2) (Slack, 1984 ) using a Drummond microinjector with an injection volume of 4.6 nl per cell. Zygotes were tilted in 4% agarose wells by 90" for about 30 min with the sperm entry site facing down in order to fix the position of the dorsal side opposite the sperm entry site (Gimlich, 1986; Kao et al., 1986) which was marked with crystal of Nile blue sulfate.
